Bausch & Lomb (TSX:BLCO) Cost of Goods Sold : C$2,212 Mil (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Bausch & Lomb Cost of Goods Sold?

Bausch & Lomb's cost of goods sold for the three months ended in Dec. 2023 was C$618 Mil. Its cost of goods sold for the trailing twelve months (TTM) ended in Dec. 2023 was C$2,212 Mil.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Bausch & Lomb's Gross Margin % for the three months ended in Dec. 2023 was 60.7%.

Cost of Goods Sold is also directly linked to Inventory Turnover. Bausch & Lomb's Inventory Turnover for the three months ended in Dec. 2023 was 0.52.

Bausch & Lomb Cost of Goods Sold Historical Data

The historical data trend for Bausch & Lomb's Cost of Goods Sold can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch & Lomb Cost of Goods Sold Chart

Bausch & Lomb Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cost of Goods Sold

Get a 7-Day Free Trial

1,747.53

1,645.96

1,877.76

2,063.56

2,202.91

Bausch & Lomb Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Cost of Goods Sold	Get a 7-Day Free Trial											570.57	509.01	554.03	530.42	618.48

Bausch & Lomb Cost of Goods Sold Calculation

Cost of Goods Sold is the aggregate cost of goods produced and sold, and services rendered during the reporting period. It excludes Total Operating Expense, such as Depreciation, Depletion and Amortization and Selling, General, & Admin. Expense.

Cost of Goods Sold for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2,212 Mil.

Bausch & Lomb (TSX:BLCO) Cost of Goods Sold Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Bausch & Lomb's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %	=	(Revenue	-	Cost of Goods Sold)	/	Revenue
	=	(1573.697	-	618.478)	/	1573.697
	=	60.7 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Cost of Goods Sold is also directly linked to another concept called Inventory Turnover:

Bausch & Lomb's Inventory Turnover for the three months ended in Dec. 2023 is calculated as:

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	618.478	/	1199.701
	=	0.52

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher inventory turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate inventory turnover. An average inventory is a better indication.

Bausch & Lomb Cost of Goods Sold Related Terms

Thank you for viewing the detailed overview of Bausch & Lomb's Cost of Goods Sold provided by GuruFocus.com. Please click on the following links to see related term pages.

Bausch & Lomb (TSX:BLCO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bausch & Lomb Corp (TSX:BLCO) » Definitions » Cost of Goods Sold

Comparable Companies

Traded in Other Exchanges

BLCO:USA S2L:Germany

Address

520 Applewood Crescent, Vaughan, ON, CAN, L4K 4B4

Website

https://www.bausch.com

Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.